Kappa B-specific DNA binding proteins: role in the regulation of human interleukin-2 gene expression
about
Interleukin-18 promotes sleep in rabbits and ratsI kappa B/MAD-3 masks the nuclear localization signal of NF-kappa B p65 and requires the transactivation domain to inhibit NF-kappa B p65 DNA bindingA novel NF-kappa B complex containing p65 homodimers: implications for transcriptional control at the level of subunit dimerizationInhibition of NF-AT-dependent transcription by NF-kappa B: implications for differential gene expression in T helper cell subsetsThe human interleukin-2 receptor beta-chain gene: genomic organization, promoter analysis and chromosomal assignmentT helper cell activation and human retroviral pathogenesisPolymorphic structure of the tumor necrosis factor (TNF) locus: an NcoI polymorphism in the first intron of the human TNF-beta gene correlates with a variant amino acid in position 26 and a reduced level of TNF-beta productionFunctional analysis of the human interleukin 2 receptor gamma chain gene promoterMode of action of SDZ NIM 811, a nonimmunosuppressive cyclosporin A analog with activity against human immunodeficiency virus type 1 (HIV-1): interference with early and late events in HIV-1 replicationThe c-rel protooncogene product c-Rel but not NF-kappa B binds to the intronic region of the human interferon-gamma gene at a site related to an interferon-stimulable response elementRegulation of tumor necrosis factor alpha transcription in macrophages: involvement of four kappa B-like motifs and of constitutive and inducible forms of NF-kappa BActivation of interleukin-6 gene expression through the NF-kappa B transcription factorFolate MetabolismRetroviruses and cancer: models for cancer in animals and humans.cis-acting sequences required for inducible interleukin-2 enhancer function bind a novel Ets-related protein, Elf-1.Interaction of an NF-kappa B-like factor with a site upstream of the c-myc promoterTumor necrosis factor and immune interferon synergistically increase transcription of HLA class I heavy- and light-chain genes in vascular endotheliumROG negatively regulates T-cell activation but is dispensable for Th-cell differentiation.Human immunodeficiency virus type 1 Nef protein inhibits NF-kappa B induction in human T cells.Negative transcriptional regulation of human interleukin 2 (IL-2) gene by glucocorticoids through interference with nuclear transcription factors AP-1 and NF-AT.NF-kappa B: a family of inducible and differentially expressed enhancer-binding proteins in human T cells.Activation of the human immunodeficiency virus type 1 long terminal repeat by vaccinia virus.PharmGKB summary: cyclosporine and tacrolimus pathwaysIonizing radiation induces expression and binding activity of the nuclear factor kappa B.Control of lymphokine expression in T helper 2 cells.The E3 ubiquitin ligase mind bomb-2 (MIB2) protein controls B-cell CLL/lymphoma 10 (BCL10)-dependent NF-κB activation.MUC1 protein expression in tumor cells regulates transcription of proinflammatory cytokines by forming a complex with nuclear factor-κB p65 and binding to cytokine promoters: importance of extracellular domain.An essential role for nuclear factor kappaB in promoting double positive thymocyte apoptosis.Characterization of the sequence and architectural constraints of the regulatory and core regions of the human interleukin-2 promoter.Activation of the IL-2 gene promoter by HTLV-I tax involves induction of NF-AT complexes bound to the CD28-responsive element.Immune factor Gambif1, a new rel family member from the human malaria vector, Anopheles gambiaeProtein kinase Calpha (PKCalpha) acts upstream of PKCtheta to activate IkappaB kinase and NF-kappaB in T lymphocytes.The weak, fine-tuned binding of ubiquitous transcription factors to the Il-2 enhancer contributes to its T cell-restricted activity.Selective autophagy of the adaptor protein Bcl10 modulates T cell receptor activation of NF-κB.High-Dose Nicotinamide Suppresses ROS Generation and Augments Population Expansion during CD8(+) T Cell ActivationGlucocorticoid receptor-mediated suppression of the interleukin 2 gene expression through impairment of the cooperativity between nuclear factor of activated T cells and AP-1 enhancer elements.The AP-1 site at -150 bp, but not the NF-kappa B site, is likely to represent the major target of protein kinase C in the interleukin 2 promoter.Differential induction of transcription factors that regulate the interleukin 2 gene during anergy induction and restimulationStructure of the mouse pore-forming protein (perforin) gene: analysis of transcription initiation site, 5' flanking sequence, and alternative splicing of 5' untranslated regions.Antibodies against major histocompatibility complex class II antigens directly inhibit the growth of T cells infected with Theileria parva without affecting their state of activation.
P2860
Q24291568-EB96E724-AEE9-48D3-8B7A-E8F43F4B544BQ24307786-8D6290C8-46D1-4188-894B-F1E9F3EEED01Q24320246-AAC02510-7F34-4EE6-8385-62BDC9C15640Q24564467-ED7D3533-92E5-427B-B250-837C618A02E7Q24611277-1EDB720A-3F15-41A9-ADD3-CFD128AC98FDQ24650854-9E7012F5-8AD3-488F-9B70-C760C598DAFFQ24676008-BF6FF762-0127-4152-BF38-34073CCA70BAQ28299407-60B7CC51-A0B5-451C-B893-202881541926Q28368266-70BE68D1-21BA-444C-9478-8EE17363343BQ28645819-5FFF26FB-5043-4288-AF27-5E9A404059F4Q28645847-2557062C-6490-4682-95A7-B32050DFD020Q28646310-F7B43C97-94B8-41AC-B6F6-7E29683A5F8AQ30225387-31850B2B-FEBF-48B8-91A0-285882DAB246Q30467457-158C9E48-38BC-4CA3-97C3-D692E2DAFCB0Q31117684-50AEE5F1-1834-4D35-A760-8A85C1C10C09Q33641587-62DE1D2D-D5DF-44A5-9F97-FFC94DF9978EQ33672681-0C1E1BF2-EF38-47F9-B138-899CB28A0B10Q33695741-6385CDA1-04BF-442B-89C7-D26CCF9556BFQ33720212-3FB4C8AE-0139-492C-B945-598D878FC4A7Q33895733-CF672016-0F1B-4003-8FEF-1FE3D16150C8Q33927973-49CAC2E3-81A0-4015-A77E-31AF18798C62Q33930958-C888214D-2249-4EAA-B50D-A3E0A53CA08BQ33989902-07E24027-6682-4BFD-BD0C-523F93A1C0D5Q34194765-737E7072-9B3E-4480-9BA8-44D29F453116Q34323615-F6012FAE-F6FB-4B22-B84F-C8514B30E305Q35423381-DADDB201-FF59-421F-8616-709EA93B70AFQ35605048-D47A097B-400E-4793-AC15-470EB7409B24Q35834615-14A1BAA2-1D89-4498-8B57-C2C9B826F330Q35901010-FCEE3ACE-F567-4CC7-8032-9846C9035D5BQ35903756-8884585E-D577-4BBB-A8DA-516DC658AB3AQ35907925-0BAB48EF-D5EF-468A-A496-02609AFBE75BQ35924279-A8925382-F94F-43B3-A174-C979E025EC15Q36013163-B87B755C-9F48-485D-82D1-8CEDE573F44BQ36074808-18A8CA63-8855-48B8-93AD-8AEBBA05625AQ36221473-9F72FAFE-3DDA-40A3-8184-FD2DA2FC3C72Q36231008-D2596BF0-AB10-430F-8E87-1C3A99BEAA9CQ36231038-8C3AD350-7A47-484D-B585-773EFC5051D0Q36231212-912917CB-99A9-4A7E-A9E1-B1E6501ADCD6Q36360932-A2603243-0385-40ED-9025-A9B48054EB11Q36362189-0D3C04FC-7185-4475-A3CB-C9569DA7BF27
P2860
Kappa B-specific DNA binding proteins: role in the regulation of human interleukin-2 gene expression
description
1989 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
article publié dans la revue scientifique Science
@fr
artículu científicu espublizáu en 1989
@ast
im April 1989 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 1989/04/28)
@sk
vědecký článek publikovaný v roce 1989
@cs
wetenschappelijk artikel (gepubliceerd op 1989/04/28)
@nl
наукова стаття, опублікована у квітні 1989
@uk
name
Kappa B-specific DNA binding p ...... interleukin-2 gene expression
@ast
Kappa B-specific DNA binding p ...... interleukin-2 gene expression
@en
Kappa B-specific DNA binding p ...... interleukin-2 gene expression
@nl
type
label
Kappa B-specific DNA binding p ...... interleukin-2 gene expression
@ast
Kappa B-specific DNA binding p ...... interleukin-2 gene expression
@en
Kappa B-specific DNA binding p ...... interleukin-2 gene expression
@nl
prefLabel
Kappa B-specific DNA binding p ...... interleukin-2 gene expression
@ast
Kappa B-specific DNA binding p ...... interleukin-2 gene expression
@en
Kappa B-specific DNA binding p ...... interleukin-2 gene expression
@nl
P2093
P356
P1433
P1476
Kappa B-specific DNA binding p ...... interleukin-2 gene expression
@en
P2093
D. W. Ballard
E. Böhnlein
M. Siekevitz
W. C. Greene
P304
P356
10.1126/SCIENCE.2497518
P407
P577
1989-04-28T00:00:00Z